Russell Investments Group, Ltd. - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 21 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$3,380,328
+46.0%
3,384,000
+45.7%
0.01%
+40.0%
Q4 2022$2,315,739
+23.5%
2,323,000
+21.6%
0.01%
+25.0%
Q3 2022$1,875,000
+18.7%
1,910,000
+20.1%
0.00%
+33.3%
Q2 2022$1,579,000
+10.2%
1,590,000
+3.0%
0.00%
+50.0%
Q1 2022$1,433,000
-1.2%
1,543,000
+2.5%
0.00%0.0%
Q4 2021$1,451,000
-10.0%
1,506,000
-25.0%
0.00%
-33.3%
Q3 2020$1,613,000
-42.9%
2,007,000
-46.5%
0.00%
-50.0%
Q2 2020$2,823,000
+113.9%
3,752,000
+127.4%
0.01%
+100.0%
Q1 2020$1,320,000
+52.6%
1,650,000
+92.3%
0.00%
+50.0%
Q4 2019$865,000
+291.4%
858,000
+284.8%
0.00%
Q1 2019$221,000
-27.1%
223,000
-32.2%
0.00%
-100.0%
Q4 2018$303,000
-55.8%
329,000
-51.5%
0.00%0.0%
Q3 2018$686,000
-32.7%
679,000
-41.7%
0.00%
-50.0%
Q2 2018$1,019,000
-42.2%
1,164,000
-47.1%
0.00%
-33.3%
Q1 2018$1,763,000
+129.9%
2,200,000
+131.6%
0.00%
+200.0%
Q4 2017$767,000
+35.5%
950,000
+30.1%
0.00%0.0%
Q3 2017$566,000
-20.5%
730,0000.0%0.00%0.0%
Q2 2017$712,000
-2.3%
730,000
-6.4%
0.00%0.0%
Q1 2017$729,000
+4.1%
780,0000.0%0.00%0.0%
Q4 2016$700,000780,0000.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Silver Point Capital L.P. 57,420,000$44,527,0005.17%
Birch Grove Capital LP 10,003,000$7,934,0004.14%
PenderFund Capital Management Ltd. 9,605,000$9,491,0002.41%
Context Capital Management, LLC 9,887,000$7,671,0001.05%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 57,791,000$45,738,0000.90%
DeepCurrents Investment Group LLC 35,892,000$27,953,0000.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 22,977,000$18,267,0000.70%
WHITEBOX ADVISORS LLC 23,150,000$17,847,0000.56%
ADVENT CAPITAL MANAGEMENT /DE/ 27,397,000$21,720,0000.46%
OAKTREE CAPITAL MANAGEMENT LP 19,435,000$15,079,0000.26%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders